补充温卡明的疾病修饰效应
Francisco José Sanz1,2, Cristina Solana-Manrique1,2,3, Nuria Paricio1,2
1Departamento de Genética, Facultad de Ciencias Biológicas, Universidad de Valencia, Burjassot 46100, Spain.
芬卡明是一种天然化合物,在治疗帕金森病 (PD) 中表现有前途. 它改善了PD模型中的运动功能和减少了氧化应激,这表明它是潜在的治疗剂.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特征是多巴胺能神经元的损失.
- 目前的PD治疗提供症状缓解,但不能阻止疾病的进展.
- 氧化应激在PD病变发生过程中起着重要作用.
研究的目的:
- 为了确定帕金森病的新疗法化合物.
- 在临床前PD模型中评估芬卡明 (VIN) 的疗效.
- 调查卡胺潜在治疗效果背后的机制.
主要方法:
- 使用Drosophila和人类PD细胞模型对化合物的高通量选.
- 对DJ-1突变的运动运动活动的评估.
- 在缺乏DJ-1的人类细胞中评估细胞活力,细胞亡和氧化应激水平.
- 调查温卡明对电压导入通道的影响.
主要成果:
- 文卡明 (VIN) 改善了PD的Drosophila模型中的运动能力.
- 在缺乏DJ-1的人类细胞中,VIN降低了氧化应激和OS诱导的致死性.
- 在人类PD模型中,VIN降低了亡并增加了线粒体活力.
- 芬卡明的有益作用可能涉及抑制电压门的通道.
结论:
- 文卡明通过减轻PD相关的表型,证明了对帕金森病的治疗潜力.
- 电压导入通道的抑制代表了PD的潜在治疗标.
- 芬卡明是进一步开发PD治疗的有希望的候选药物.
更多相关视频
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
相关概念视频
Drugs that Destabilize Microtubules
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
